Profile data is unavailable for this security.
About the company
PT Penta Valent Tbk is engaged in the distribution of pharmaceutical products, medical equipment and consumer products. The pharmaceutical products or medicines and medical devices distributed by the Company are divided into several types, including ethical products, which are medicines sold in limited quantities and require a doctor’s prescription; Over The Counter products, which are medicines sold freely; Medical Devices, which are medical supporting devices such as blood pressure monitors, nebulizer, kateter, and others; Reagents, which are reaction materials such as blood sugar tests, pregnancy tests, or rapid tests for Covid-19, drug tests, and others; as well as Food Supplements. Its distribution of consumer goods, which is divided into two types of products, namely Cosmetics: products for beauty and skin care, including makeup, perfume, skin nutrition, and others; and Toiletries: products for daily cleanliness and hygiene such as soap, shampoo, toothpaste, lotion, and other.
- Revenue in IDR (TTM)2.66tn
- Net income in IDR40.79bn
- Incorporated2015
- Employees--
- LocationPenta Valent Tbk PTKedoya Utara Kebon JerukJI Kedoya raya no 33JAKARTA BARAT 11520IndonesiaIDN
- Phone+62 215673891
- Websitehttps://www.pentavalent.co.id/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Multi Indocitra Tbk PT | 1.09tn | 32.08bn | 288.00bn | 404.00 | 8.86 | 0.317 | 5.31 | 0.2633 | 54.19 | 54.19 | 1,847.86 | 1,513.98 | 0.8571 | 1.60 | 5.22 | 2,762,183,000.00 | 2.51 | 2.85 | 3.70 | 4.01 | 46.06 | 50.65 | 2.93 | 3.69 | 0.7617 | 2.71 | 0.2496 | -- | 11.49 | 11.24 | -27.97 | 0.8175 | -21.71 | -- |
Exceed World Inc | 373.03bn | -21.54bn | 343.27bn | 41.00 | -- | 1.33 | -- | 0.9202 | -0.0405 | -0.0405 | 0.702 | 0.4873 | 0.8953 | 10.42 | 424.59 | 559,890.50 | -5.17 | 4.14 | -7.27 | 6.17 | 50.19 | 48.99 | -5.77 | 4.02 | 3.01 | -622.74 | 0.0019 | -- | -25.27 | -5.76 | -113.33 | -- | -31.13 | -- |
Liberta Co Ltd | 763.56bn | -727.62m | 368.13bn | 118.00 | -- | 2.45 | 24.59 | 0.4821 | -2.34 | -2.34 | 2,487.28 | 482.67 | 1.20 | 2.67 | 7.65 | 62,643,520.00 | -0.1068 | 3.75 | -0.2169 | 6.42 | 38.24 | 41.81 | -0.0891 | 2.37 | 0.8247 | 3.15 | 0.6948 | 35.67 | 6.77 | 9.76 | -2.77 | -12.85 | 23.12 | -- |
Medical Developments International Ltd | 362.11bn | -207.70bn | 396.55bn | 68.00 | -- | 0.4846 | -- | 1.10 | -0.2226 | -0.2226 | 0.3882 | 0.877 | 0.3348 | 1.01 | 6.18 | -- | -19.20 | -6.67 | -22.18 | -7.43 | 69.64 | 69.90 | -57.36 | -23.55 | 1.93 | -- | 0.0311 | -- | 47.37 | 13.12 | 54.79 | -- | -6.41 | -- |
Delko SA | 3.72tn | 69.14bn | 412.51bn | 1.16k | 5.97 | 0.6426 | 3.04 | 0.1108 | 1.40 | 1.40 | 75.48 | 13.01 | 2.65 | 0.1680 | 11.04 | -- | 4.93 | -- | 8.46 | -- | 98.30 | -- | 1.86 | -- | 0.7361 | 849.72 | 0.3958 | -- | -- | -- | -- | -- | -- | -- |
Penta Valent Tbk PT | 2.66tn | 40.79bn | 476.72bn | -- | 11.56 | 1.97 | 10.25 | 0.1794 | 23.36 | 23.36 | 1,525.15 | 137.39 | 3.06 | 8.95 | 6.37 | -- | 4.69 | -- | 15.53 | -- | 12.01 | -- | 1.54 | -- | 0.9258 | 11.07 | 0.2678 | -- | 15.71 | -- | 53.62 | -- | -- | -- |
Rhone Ma Holdings Bhd | 711.69bn | 42.02bn | 504.07bn | -- | 16.34 | 0.8893 | 8.35 | 0.7083 | 0.0404 | 0.0404 | 0.6842 | 0.7422 | 0.9424 | 2.93 | 4.98 | -- | 6.26 | 6.15 | 7.47 | 7.38 | 26.40 | 28.11 | 6.64 | 6.85 | 2.91 | 13.36 | 0.144 | 32.11 | 2.41 | 8.46 | -5.16 | 3.72 | -27.03 | -7.79 |
EZZ Life Science Holdings Ltd | 472.60bn | 37.55bn | 511.37bn | -- | 13.08 | 2.97 | 12.49 | 1.08 | 0.0814 | 0.0814 | 1.02 | 0.3582 | 2.48 | 9.63 | 13.51 | -- | 19.69 | 21.22 | 24.85 | 29.19 | 74.77 | 55.31 | 7.94 | 9.11 | 3.61 | 293.27 | 0.0195 | 13.08 | 147.26 | -- | 176.57 | -- | -- | -- |
Microalliance Group Inc | 371.86bn | 159.53bn | 595.07bn | 30.00 | 4.44 | 1.20 | 3.68 | 1.60 | 0.0135 | 0.0135 | 0.0325 | 0.0501 | 0.7631 | 0.4869 | 12.65 | 762,790.30 | 32.74 | -- | 35.89 | -- | 68.46 | -- | 42.90 | -- | 12.67 | -- | 0.00 | -- | 3,030.68 | -- | 3,074.43 | -- | -- | -- |
COSMO BIO COMPANY, LIMITED | 976.66bn | 42.14bn | 628.48bn | 155.00 | 14.38 | 0.6593 | 10.71 | 0.6435 | 69.94 | 69.94 | 1,620.67 | 1,525.81 | 0.8484 | 6.09 | 2.87 | 61,000,000.00 | 3.80 | 5.62 | 4.54 | 6.72 | 33.82 | 37.40 | 4.48 | 6.23 | 5.15 | -- | 0.0021 | 33.53 | -2.23 | 5.16 | -14.51 | 11.20 | -8.03 | 16.47 |